Kadokawa Corporation
Kadokawa Corporation (9468.T) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Kadokawa Corporation (9468.T), featuring income statements, balance sheets, and cash flow data.
Kadokawa Corporation (9468.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Kadokawa Corporation 9468.T financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $71.33B | $70.27B | $70.46B | $65.86B |
| Cost of Revenue | $48.61B | $44.19B | $45.43B | $40.60B |
| Gross Profit | $22.72B | $26.08B | $25.03B | $25.26B |
| Gross Profit Ratio | $0.32 | $0.37 | $0.36 | $0.38 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $21.90B | $20.87B | $20.43B | $19.23B |
| Operating Expenses | $21.90B | $20.86B | $20.43B | $19.23B |
| Total Costs & Expenses | $70.51B | $65.06B | $65.86B | $59.83B |
| Interest Income | $365.00M | $289.00M | $446.00M | $421.00M |
| Interest Expense | $24.00M | $18.00M | $26.00M | $12.00M |
| Depreciation & Amortization | $2.56B | $2.02B | $1.92B | $1.76B |
| EBITDA | $2.99B | $7.23B | $6.51B | $7.79B |
| EBITDA Ratio | $0.04 | $0.10 | $0.09 | $0.12 |
| Operating Income | $814.00M | $5.21B | $4.60B | $6.03B |
| Operating Income Ratio | $0.01 | $0.07 | $0.07 | $0.09 |
| Other Income/Expenses (Net) | -$410.00M | $2.34B | -$2.79B | $1.40B |
| Income Before Tax | $404.00M | $7.55B | $1.81B | $7.43B |
| Income Before Tax Ratio | $0.006 | $0.11 | $0.03 | $0.11 |
| Income Tax Expense | $21.00M | $2.65B | $1.22B | $3.36B |
| Net Income | $26.00M | $4.27B | -$358.00M | $3.45B |
| Net Income Ratio | $0.00 | $0.06 | -$0.005 | $0.05 |
| EPS | $0.18 | $30.56 | -$3.47 | $25.69 |
| Diluted EPS | $0.19 | $29.80 | -$2.66 | $25.48 |
| Weighted Avg Shares Outstanding | $137.24M | $139.74M | $134.46M | $134.45M |
| Weighted Avg Shares Outstanding (Diluted) | $137.24M | $143.31M | $134.46M | $135.56M |
Over the last four quarters, Kadokawa Corporation achieved steady financial progress, growing revenue from $65.86B in Q1 2024 to $71.33B in Q4 2024. Gross profit stayed firm with margins at 32% in Q4 2024 versus 38% in Q1 2024. Operating income totaled $814.00M in Q4 2024, maintaining a 1% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $2.99B. Net income dropped to $26.00M, with EPS at $0.18. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan